EXTRAWELL PHAR (00858) announces that it is expected to achieve a mid-term profit of approximately HK$100 million to HK$105 million, turning a loss into a profit on a year-on-year basis.

date
19/11/2024
avatar
GMT Eight
Excellent Pharmaceutical (00858) announced that the group expects to achieve profitability for the six months ending September 30, 2024.
EXTRAWELL PHAR (00858) has announced that the group is expected to achieve a profit of approximately HK$100 million to HK$105 million for the six months ending on September 30, 2024, compared to a loss for the same period ending on September 30, 2023. The expected turnaround from loss to profit for this period is mainly due to non-cash items, specifically income generated from fair value changes in financial assets recognized in the income statement, as opposed to losses from fair value changes in the same non-cash items for the corresponding period in 2023.